Navigation Links
Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
Date:9/29/2010

EAST NORRITON, Pa., Sept. 29 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN) presented new research data yesterday in a podium presentation at the 2nd Annual Symposium on Stem Cell Translation of the International Society for Cellular Therapy (ISCT) in San Francisco.  The presentation highlighted new results from Tengion's Neo-Kidney Augment™ development program demonstrating success with an autologous cellular therapy approach to kidney regeneration in a rodent model of obesity, diabetes and hypertension.  

"These data demonstrate that our proprietary therapeutic approach using cells from diseased kidney tissue can provide significant improvements in several parameters of kidney function, including filtration, urine concentration, and electrolyte balance, as well as a significant reduction in blood pressure," stated Sharon Presnell, Ph.D., Vice President of Regenerative Medicine at Tengion.  "We used the established ZSF1 rodent model, which develops chronic kidney disease as a result of obesity, diabetes, and hypertension – three common co-morbid conditions often seen in patients with renal failure.  Although our studies are still active, at one year of age, the treated animals have demonstrated improved kidney function, delayed disease progression and better survival compared to the age- and disease-matched untreated control animals." 

"Following our recently published and peer-reviewed data from a nephrectomized model of renal failure, these new results in a model of natural disease progression further strengthen our confidence in this program," said Tim Bertram, D.V.M., Ph.D., Senior Vice President, Science and Technology at Tengion.  "We look forward to presenting additional data from this development program in the fourth quarter of this year."  

Tengion's Neo-Kidney Augment product candid
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
2. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
3. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
4. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
5. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
8. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... announce that TUV-SUD and The Medicinal Evaluation Board ... has granted its request for a label expansion ... initially approved in July 2013 for use in ...
(Date:9/22/2014)... PLEASANTON, Calif. , Sept. 22, 2014 ... leader in device-based mechanical circulatory support therapies to save, ... D. Keith Grossman has been appointed President and ... F. Burbach , who has stepped down from his ... advisor to the company through the first quarter of ...
(Date:9/22/2014)... Sept. 22, 2014 Auxilium Pharmaceuticals, Inc. ... company, today announced that its Board of Directors ... conditional proposal from Endo International plc ("Endo") and, ... advisors, has unanimously determined it is not a ... merger agreement with QLT Inc. ("QLT") and has ...
Breaking Medicine Technology:Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6
... Based on its recent analysis of the ... Hybridyne Technologies, Inc. with the 2010 North American ... the Year. (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ... ProxiScan™, recently approved by the FDA, is ...
... Upstate New York Laboratory Robotics Interest Group (LRIG) ... Society of Mechanical Engineers (ASME) will be hosting ... 27, 2010 entitled "Unconventional High-Throughput Applications," featuring Pankaj ... Seth Cohen, Ph.D., Senior Director Microfluidics Applications, Caliper ...
Cached Medicine Technology:Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation 2Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation 3Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation 4Upstate New York Laboratory Robotics Interest Group (LRIG) to Host Free Symposium and Exhibition 2
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... September 22, 2014 This Flash Report ... stakeholder management needs for the Prostate Cancer market. , ... on stakeholder strategies for any launching Prostate Cancer product:, ... differentiation within an increasingly crowded market , ... impact of identifying community-based thought leaders and stakeholders ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 The R&D ... the recent years. The statistically important data received from ... of cancer vaccines. The primary challenge to the development ... about the exact mechanism of how a human’s immune ... various results in different individuals owing to known factors ...
(Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- Two new prescription ... (FDA) may provide some relief for people with migraine ... a new study. One device -- the Cefaly ... device -- the Cerena -- is meant to be ... news release. "Patients have been looking for alternative ...
(Date:9/22/2014)... Nanuet, NY (PRWEB) September 22, 2014 ... Blindness, Rockland Chrysler Jeep Dodge Ram is launching an ... Blind Egg Challenge (#blindeggchallenge or #ffbBEC) aims to raise ... Egg Challenge involves throwing an egg in the air ... at least three others and if a nominee does ...
Breaking Medicine News(10 mins):Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Blind Egg Challenge Raises Awareness for Foundation Fighting Blindness 2
... ... in pursing careers in medical transcription and medical coding and billing. , ... Provo, Utah (PRWEB) June 5, ... Community College in Roxboro, N.C. to offer training to individuals interested in pursing careers ...
... announced today its decision to expand its use of ... sanitizer, to all its service centers nationwide after testing ... the first major healthcare laundry processor to implement the ... wash process will elevate the standard of cleanliness in ...
... Univision, People en Espanol, Ser Padres and impreMedia health expert Aliza ... Doctora Aliza (TM), announced the launch of her Spanish-language health hub ... http://www.newscom.com/cgi-bin/prnh/20090604/SF28145 ) , , " VidaySalud.com ... wellness tools in Spanish on the web. It includes ...
... Gift Cards, Inspiring Star Cards Make Giving Easy , ... Maggiano,s Little Italy(R) restaurants begin the sixth annual "Eat-A-Dish ... five Chicago-area Maggiano,s are taking part in the program ... the nonprofit organization that makes wishes come true for ...
... Up 191% - , , - Total Net Sales in Line ... be Held Today at 3:30 pm Central Time - ... UPI ), a medical device company that develops, manufactures and markets innovative ... fourth quarter and full year ended March 31, 2009. Net sales ...
... could mutate and become more dangerous as it travels from ... In what would seem to be some encouraging news in ... official said Thursday that samples of the virus from points ... in the United States. , "We have tested isolates from ...
Cached Medicine News:Health News:Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 2Health News:Angelica Corporation Raises Bar Again for Increased Patient Safety 2Health News:Univision's Doctora Aliza Launches VidaySalud.com(TM) 2Health News:Maggiano's Little Italy(R) Celebrates Sixth Annual 'Eat-A-Dish for Make-A-Wish(R)' in Chicago 2Health News:Maggiano's Little Italy(R) Celebrates Sixth Annual 'Eat-A-Dish for Make-A-Wish(R)' in Chicago 3Health News:Maggiano's Little Italy(R) Celebrates Sixth Annual 'Eat-A-Dish for Make-A-Wish(R)' in Chicago 4Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 2Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 3Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 4Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 5Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 6Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 7Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 8Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 9Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 10Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 11Health News:Global Testing Shows No Variation in Swine Flu Virus 2Health News:Global Testing Shows No Variation in Swine Flu Virus 3Health News:Global Testing Shows No Variation in Swine Flu Virus 4Health News:Global Testing Shows No Variation in Swine Flu Virus 5Health News:Global Testing Shows No Variation in Swine Flu Virus 6Health News:Global Testing Shows No Variation in Swine Flu Virus 7Health News:Global Testing Shows No Variation in Swine Flu Virus 8Health News:Global Testing Shows No Variation in Swine Flu Virus 9Health News:Global Testing Shows No Variation in Swine Flu Virus 10Health News:Global Testing Shows No Variation in Swine Flu Virus 11
Designed to meet the requirements of reagent grade water for routine analysis....
... L/min of Type I ultrapure water, , ... Plus System is designed to provide the ... pretreated by reverse osmosis, distillation or deionization. ... quality which exceeds Type I ASTM/CAP/NCCLS specifications.,The ...
... Basic Laboratory Needs, Synergy systems produce ultrapure water ... 1 to 1.2 L/min to meet the basic ... incorporates a dual-wavelength UV lamp (185 nm and ... of organic contaminants (< 5 ppb TOC when ...
... Compact System Produces Type I Water Directly from ... designed for scientists who need 5 to 15 ... not have easy access to acceptable quality pretreated ... 0.6 L/min of ultrapure (Type I) water on ...
Medicine Products: